Targacept Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company advancing NNR Therapeutics™, today announced it will report financial results for the second quarter of 2014 on Wednesday, August 6, 2014, before the U.S. financial markets open.
Help employers find you! Check out all the jobs and post your resume.
